SCHEMBL20976434

SCHEMBL20976434

COc1c(CO)cc(S(F)(F)F)cc1NC(=O)NC1CCCCC1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.47
▸ MEN1 O00255 2/20 0.47
▸ POLB P06746 2/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ LMNA P02545 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ KDM4E B2RXH2 2/20 0.44
▸ NPC1 O15118 3/20 0.44
▸ RAB9A P51151 3/20 0.44
▸ EPHX1 P07099 1/20 0.44
▸ EPHX2 P34913 1/20 0.44
▸ HTT P42858 1/20 0.43
▸ CA12 O43570 1/20 0.43
▸ CA1 P00915 1/20 0.43
▸ CA9 Q16790 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18615487 0.83 MAPK14 (0.49) KMT2AMEN1POLBSMN1; SMN2KDM4E
SCHEMBL18615444 0.83 KMT2A (0.47) KMT2AMEN1POLBALDH1A1SMN1; SMN2
SCHEMBL18615479 0.81 EPHX2 (0.53) KMT2AMEN1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL20365331 0.70 EPHX2 (0.50) KMT2AMEN1ALDH1A1LMNAMAPT
SCHEMBL2752584 0.68 POLB (0.65) KMT2AMEN1POLBALDH1A1LMNA
SCHEMBL20357294 0.67 MAPK14 (0.44) POLBALDH1A1LMNAMAPTKDM4E
SCHEMBL18615489 0.67 MAPK14 (0.44) POLBALDH1A1LMNAMAPTKDM4E
SCHEMBL20365336 0.66 EPHX2 (0.52) KMT2AMEN1POLBSMN1; SMN2NPC1
SCHEMBL10320067 0.66 MAPK14 (0.67) KMT2AMEN1MAPTKDM4E
SCHEMBL21230467 0.65 TAS1R3 (0.71) KMT2AMEN1POLBALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10280145-B2 Urea derivative and use therefor TORAY INDUSTRIES, INC. (JP) 2019-05-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10280145-B2 Urea derivative and use therefor UTS2R, DDR1, WEE1 KMT2A 3875/4885MEN1 603/4885POLB 4268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback